Skip to main content
PMC home page
Journal of Virology logoLink to Journal of Virology
. 1991 Sep;65(9):5052–5060. doi: 10.1128/jvi.65.9.5052-5060.1991

Antibody enhancement of respiratory syncytial virus stimulation of leukotriene production by a macrophagelike cell line.

G A Ananaba 1, L J Anderson 1
PMCID: PMC248969  PMID: 1870211

Abstract

The clinical and epidemiologic features of respiratory syncytial virus (RSV) infections suggest that RSV-specific antibody may sometimes contribute to the disease process. Recently, it has been demonstrated that virus-specific antibody can enhance RSV infection of macrophagelike cells in vitro. We evaluated the possibility that antibody might also enhance RSV stimulation of the bronchoactive mediator of inflammation leukotriene C-4 (LTC4)in a macrophagelike cell line, U937. The addition of RSV led to little increase in LTC4 production, but addition of RSV plus anti-RSV antibody increased production to a level similar to that achieved with calcium ionophore, a known stimulator of LTC4 production. The antibody-enhanced increase in LTC4 production occurred rapidly (within 15 min), peaked at 60 min, and achieved levels 1.5- to 3.0-fold above that for cells or cells plus virus. RSV plus anti-RSV antibodies in the form of polyclonal serum, monoclonal antibodies, or F(ab')2 fragments and parainfluenza virus types 1 and 3 plus their respective antibodies all increased LTC4 levels over that for the virus alone. These results demonstrate that antibody plus the corresponding virus or protein can increase leukotriene production. This phenomenon could contribute to diseases, such as RSV bronchiolitis, that appear to be caused by an interaction between the virus (or antigen) and host immunity.

Full text

PDF
5052

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aehringhaus U., Wölbling R. H., König W., Patrono C., Peskar B. M., Peskar B. A. Release of leukotriene C4 from human polymorphonuclear leucocytes as determined by radioimmunoassay. FEBS Lett. 1982 Sep 6;146(1):111–114. doi: 10.1016/0014-5793(82)80715-1. [DOI] [PubMed] [Google Scholar]
  2. Anderson L. J., Bingham P., Hierholzer J. C. Neutralization of respiratory syncytial virus by individual and mixtures of F and G protein monoclonal antibodies. J Virol. 1988 Nov;62(11):4232–4238. doi: 10.1128/jvi.62.11.4232-4238.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Anderson L. J., Coombs R. A., Tsou C., Hierholzer J. C. Use of the biotin-avidin system to study the specificity of antibodies against respiratory syncytial virus. J Clin Microbiol. 1984 Jun;19(6):934–936. doi: 10.1128/jcm.19.6.934-936.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Anderson L. J., Hierholzer J. C., Bingham P. G., Stone Y. O. Microneutralization test for respiratory syncytial virus based on an enzyme immunoassay. J Clin Microbiol. 1985 Dec;22(6):1050–1052. doi: 10.1128/jcm.22.6.1050-1052.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Anderson L. J., Hierholzer J. C., Stone Y. O., Tsou C., Fernie B. F. Identification of epitopes on respiratory syncytial virus proteins by competitive binding immunoassay. J Clin Microbiol. 1986 Mar;23(3):475–480. doi: 10.1128/jcm.23.3.475-480.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Anderson L. J., Hierholzer J. C., Tsou C., Hendry R. M., Fernie B. F., Stone Y., McIntosh K. Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies. J Infect Dis. 1985 Apr;151(4):626–633. doi: 10.1093/infdis/151.4.626. [DOI] [PubMed] [Google Scholar]
  7. Bell R. L., Kennerly D. A., Stanford N., Majerus P. W. Diglyceride lipase: a pathway for arachidonate release from human platelets. Proc Natl Acad Sci U S A. 1979 Jul;76(7):3238–3241. doi: 10.1073/pnas.76.7.3238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Busse W. W., Vrtis R. F., Dick E. C. The role of viral infections in intrinsic asthma: activation of neutrophil inflammation. Agents Actions Suppl. 1989;28:41–56. [PubMed] [Google Scholar]
  9. Castells E., George V. G., Hierholzer J. C. NCI-H292 as an alternative cell line for the isolation and propagation of the human paramyxoviruses. Arch Virol. 1990;115(3-4):277–288. doi: 10.1007/BF01310536. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cram L. S., Brunsting A. Fluorescence and light-scattering measurements on hog cholera-infected PK-15 cells. Exp Cell Res. 1973 Mar 30;78(1):209–213. doi: 10.1016/0014-4827(73)90056-6. [DOI] [PubMed] [Google Scholar]
  11. Doig M. V., Ford-Hutchinson A. W. The production and characterisation of products of the lipoxygenase enzyme system released by rat peritoneal macrophages. Prostaglandins. 1980 Dec;20(6):1007–1019. doi: 10.1016/0090-6980(80)90055-6. [DOI] [PubMed] [Google Scholar]
  12. Erdman D. D., Anderson L. J. Monoclonal antibody-based capture enzyme immunoassays for specific serum immunoglobulin G (IgG), IgA, and IgM antibodies to respiratory syncytial virus. J Clin Microbiol. 1990 Dec;28(12):2744–2749. doi: 10.1128/jcm.28.12.2744-2749.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Faden H., Kaul T. N., Ogra P. L. Activation of oxidative and arachidonic acid metabolism in neutrophils by respiratory syncytial virus antibody complexes: possible role in disease. J Infect Dis. 1983 Jul;148(1):110–116. doi: 10.1093/infdis/148.1.110. [DOI] [PubMed] [Google Scholar]
  14. Ferreri N. R., Howland W. C., Spiegelberg H. L. Release of leukotrienes C4 and B4 and prostaglandin E2 from human monocytes stimulated with aggregated IgG, IgA, and IgE. J Immunol. 1986 Jun 1;136(11):4188–4193. [PubMed] [Google Scholar]
  15. Glezen W. P., Paredes A., Allison J. E., Taber L. H., Frank A. L. Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level. J Pediatr. 1981 May;98(5):708–715. doi: 10.1016/s0022-3476(81)80829-3. [DOI] [PubMed] [Google Scholar]
  16. Glezen W. P., Taber L. H., Frank A. L., Kasel J. A. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child. 1986 Jun;140(6):543–546. doi: 10.1001/archpedi.1986.02140200053026. [DOI] [PubMed] [Google Scholar]
  17. Hierholzer J. C., Bingham P. G., Coombs R. A., Johansson K. H., Anderson L. J., Halonen P. E. Comparison of monoclonal antibody time-resolved fluoroimmunoassay with monoclonal antibody capture-biotinylated detector enzyme immunoassay for respiratory syncytial virus and parainfluenza virus antigen detection. J Clin Microbiol. 1989 Jun;27(6):1243–1249. doi: 10.1128/jcm.27.6.1243-1249.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. JOHNSON K. M., CHANOCK R. M., COOK M. K., HUEBNER R. J. Studies of a new human hemadsorption virus. I. Isolation, properties and characterization. Am J Hyg. 1960 Jan;71:81–92. doi: 10.1093/oxfordjournals.aje.a120092. [DOI] [PubMed] [Google Scholar]
  19. Joseph M., Capron A., Ameisen J. C., Capron M., Vorng H., Pancré V., Kusnierz J. P., Auriault C. The receptor for IgE on blood platelets. Eur J Immunol. 1986 Mar;16(3):306–312. doi: 10.1002/eji.1830160318. [DOI] [PubMed] [Google Scholar]
  20. Knapp H. R. Reduced allergen-induced nasal congestion and leukotriene synthesis with an orally active 5-lipoxygenase inhibitor. N Engl J Med. 1990 Dec 20;323(25):1745–1748. doi: 10.1056/NEJM199012203232506. [DOI] [PubMed] [Google Scholar]
  21. Krilov L. R., Anderson L. J., Marcoux L., Bonagura V. R., Wedgwood J. F. Antibody-mediated enhancement of respiratory syncytial virus infection in two monocyte/macrophage cell lines. J Infect Dis. 1989 Nov;160(5):777–782. doi: 10.1093/infdis/160.5.777. [DOI] [PubMed] [Google Scholar]
  22. Lewis R. A., Austen K. F., Soberman R. J. Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. N Engl J Med. 1990 Sep 6;323(10):645–655. doi: 10.1056/NEJM199009063231006. [DOI] [PubMed] [Google Scholar]
  23. Lewis R. A., Austen K. F. The biologically active leukotrienes. Biosynthesis, metabolism, receptors, functions, and pharmacology. J Clin Invest. 1984 Apr;73(4):889–897. doi: 10.1172/JCI111312. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. McKean M. L., Smith J. B., Silver M. J. Formation of lysophosphatidylcholine by human platelets in response to thrombin. Support for the phospholipase A2 pathway for the liberation of arachidonic acid. J Biol Chem. 1981 Feb 25;256(4):1522–1524. [PubMed] [Google Scholar]
  25. Morens D. M., Halstead S. B. Disease severity-related antigenic differences in dengue 2 strains detected by dengue 4 monoclonal antibodies. J Med Virol. 1987 Jun;22(2):169–174. doi: 10.1002/jmv.1890220208. [DOI] [PubMed] [Google Scholar]
  26. Ogilvie M. M., Vathenen A. S., Radford M., Codd J., Key S. Maternal antibody and respiratory syncytial virus infection in infancy. J Med Virol. 1981;7(4):263–271. doi: 10.1002/jmv.1890070403. [DOI] [PubMed] [Google Scholar]
  27. Okayama H., Aikawa T., Ohtsu H., Sasaki H., Takishima T. Leukotriene C4 and B4 in bronchoalveolar lavage fluid during biphasic allergic bronchoconstriction in sheep. Am Rev Respir Dis. 1989 Mar;139(3):725–731. doi: 10.1164/ajrccm/139.3.725. [DOI] [PubMed] [Google Scholar]
  28. Parham P. On the fragmentation of monoclonal IgG1, IgG2a, and IgG2b from BALB/c mice. J Immunol. 1983 Dec;131(6):2895–2902. [PubMed] [Google Scholar]
  29. Parker C. W. Lipid mediators produced through the lipoxygenase pathway. Annu Rev Immunol. 1987;5:65–84. doi: 10.1146/annurev.iy.05.040187.000433. [DOI] [PubMed] [Google Scholar]
  30. Peters S. P., MacGlashan D. W., Jr, Schulman E. S., Schleimer R. P., Hayes E. C., Rokach J., Adkinson N. F., Jr, Lichtenstein L. M. Arachidonic acid metabolism in purified human lung mast cells. J Immunol. 1984 Apr;132(4):1972–1979. [PubMed] [Google Scholar]
  31. Rouzer C. A., Scott W. A., Hamill A. L., Liu F. T., Katz D. H., Cohn Z. A. IgE immune complexes stimulate arachidonic acid release by mouse peritoneal macrophages. Proc Natl Acad Sci U S A. 1982 Sep;79(18):5656–5660. doi: 10.1073/pnas.79.18.5656. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Schönfeld W., Schlüter B., Hilger R., König W. Leukotriene generation and metabolism in isolated human lung macrophages. Immunology. 1988 Dec;65(4):529–536. [PMC free article] [PubMed] [Google Scholar]
  33. Scott W. A., Rouzer C. A., Cohn Z. A. Leukotriene C release by macrophages. Fed Proc. 1983 Jan;42(1):129–133. [PubMed] [Google Scholar]
  34. Shaw R. J., Walsh G. M., Cromwell O., Moqbel R., Spry C. J., Kay A. B. Activated human eosinophils generate SRS-A leukotrienes following IgG-dependent stimulation. Nature. 1985 Jul 11;316(6024):150–152. doi: 10.1038/316150a0. [DOI] [PubMed] [Google Scholar]
  35. Sundström C., Nilsson K. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer. 1976 May 15;17(5):565–577. doi: 10.1002/ijc.2910170504. [DOI] [PubMed] [Google Scholar]
  36. Volovitz B., Faden H., Ogra P. L. Release of leukotriene C4 in respiratory tract during acute viral infection. J Pediatr. 1988 Feb;112(2):218–222. doi: 10.1016/s0022-3476(88)80058-1. [DOI] [PubMed] [Google Scholar]
  37. Volovitz B., Welliver R. C., De Castro G., Krystofik D. A., Ogra P. L. The release of leukotrienes in the respiratory tract during infection with respiratory syncytial virus: role in obstructive airway disease. Pediatr Res. 1988 Oct;24(4):504–507. doi: 10.1203/00006450-198810000-00018. [DOI] [PubMed] [Google Scholar]
  38. Walsh E. E., Brandriss M. W., Schlesinger J. J. Purification and characterization of the respiratory syncytial virus fusion protein. J Gen Virol. 1985 Mar;66(Pt 3):409–415. doi: 10.1099/0022-1317-66-3-409. [DOI] [PubMed] [Google Scholar]
  39. Walsh E. E., Schlesinger J. J., Brandriss M. W. Purification and characterization of GP90, one of the envelope glycoproteins of respiratory syncytial virus. J Gen Virol. 1984 Apr;65(Pt 4):761–767. doi: 10.1099/0022-1317-65-4-761. [DOI] [PubMed] [Google Scholar]
  40. Welliver R. C., Kaul T. N., Ogra P. L. The appearance of cell-bound IgE in respiratory-tract epithelium after respiratory-syncytial-virus infection. N Engl J Med. 1980 Nov 20;303(21):1198–1202. doi: 10.1056/NEJM198011203032103. [DOI] [PubMed] [Google Scholar]
  41. Welliver R. C., Sun M., Rinaldo D., Ogra P. L. Respiratory syncytial virus-specific IgE responses following infection: evidence for a predominantly mucosal response. Pediatr Res. 1985 May;19(5):420–424. doi: 10.1203/00006450-198505000-00002. [DOI] [PubMed] [Google Scholar]
  42. Welliver R. C., Wong D. T., Sun M., Middleton E., Jr, Vaughan R. S., Ogra P. L. The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection. N Engl J Med. 1981 Oct 8;305(15):841–846. doi: 10.1056/NEJM198110083051501. [DOI] [PubMed] [Google Scholar]
  43. Williams J. D., Czop J. K., Austen K. F. Release of leukotrienes by human monocytes on stimulation of their phagocytic receptor for particulate activators. J Immunol. 1984 Jun;132(6):3034–3040. [PubMed] [Google Scholar]
  44. Williams T. J., Piper P. J. The action of chemically pure SRS-A on the microcirculation in vivo. Prostaglandins. 1980 May;19(5):779–789. doi: 10.1016/0090-6980(80)90174-4. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES